. VEGFR or CDK4/cyclin D1 inhibitor Ox-1 induces SAC inactivation in AML cells. (A) Ox-1 targets VEGFR and CDK4/cyclin D1 in AML cell line. NB4 cells were treated with different doses of Ox-1 for 48h. Cells were then collected for the immunoblotting with indicated antibodies. (B) Ox-1 treatment decreases the binding between Cdc20 and MAD2 or BubR1. NB4 cells were treated with DMSO or Ox-1 for 48h prior to harvesting. Whole cell extracts were immunoprecipitated with antibodies against Cdc20, along with IgG control, followed by immunoblotting with indicated antibodies.
Figure S2. Experimental designs. (A) & (B)
The timing of events for cell synchrony by a double thymidine block and cell cycle-specific timing of Ox-1 and CDK1 inhibition following vinblastine treatment are shown. 
